Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting

Chest

Volumn 120, Issue 3, 2001, Pages 860-865

  Wei, Minxin ^a   Kuukasjärvi, Pekka ^a   Laurikka, Jari ^a   Honkonen, Eva Liisa ^a   Kaukinen, Seppo ^a   Laine, Seppo ^a   Tarkka, Matti ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adenosine; Coronary artery bypass grafting; Cytokine responses; Myocardial injury

Indexed keywords

ADENOSINE; CREATINE KINASE MB; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY SINUS; CYTOKINE RELEASE; DOSE RESPONSE; ELECTIVE SURGERY; ENZYME RELEASE; HEART INDEX; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEMODYNAMIC MONITORING; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034820335     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3.860     Document Type: Article

References (28)

1. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes
2. 1 receptor system
3. The role of neutrophils in myocardial ischemia-reperfusion injury
4. Adenosine and cardioprotection during ischemia and reperfusion: An overview
5. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
6. Cytokine responses in low-risk coronary artery bypass surgery
7. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass
8. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
9. Cytokines as communication signals between leukocytes and endothelial cells
10. Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion
11. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells
12. Adenosine enhances IL-10 secretion by human monocytes
13. Pretreatment of human myocardium with adenosine during open heart surgery
14. Phase 1 human trial of adenosine-potassium cardioplegia
15. Phase 2 studies of adenosine cardioplegia
16. Broad spectrum cardioprotection with adenosine
17. Preconditioning of human myocardium with adenosine during coronary angioplasty
18. Intravenous adenosine and lidocaine in patients with acute myocardial infarction
19. Myocardial stunning
20. Clinical evidence for stunned myocardium after coronary artery bypass surgery
21. Adenosine: A physiological modulator of superoxide anion generation by human neutrophils
22. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery
23. Adenosine myocardial protection: Preliminary results of a phase II clinical trial
24. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry
25. Myocardial protective effects of adenosine: Infarct size reduction with pretreatment and continued receptor stimulation during ischemia
26. Adenosine attenuates in vivo myocardial stunning with minimal effects on cardiac energetics
27. Carbohydrate and CD18-dependent neutrophil adhesion to cardiac myocytes: Effects of adenosine
28. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence